L. Echegoyen, F. Diederich et al.
FULL PAPER
1477, 1455, 1238, 1094, 1044, 522 cmÀ1
;
1H NMR (500 MHz, CDCl3): d
250), 620 (sh, 700), 475 (3000), 242 nm (142000 molÀ1 dm3 cmÀ1); IR (KBr):
nÄ 2922, 1745, 1505, 1450, 1280, 1111, 1022, 522 cmÀ1; 1H NMR (500 MHz,
Cl2DCCDCl2, 808C): d 7.19 (br s, 1H), 7.05 (br s, 1H), 4.58 ± 4.45 (m, 2H),
4.58 (br q, J 7.1 Hz, 2H), 4.35 ± 4.25 (m, 2H) 4.34 (q, J 7.1 Hz, 2H), 3.97
(s, 3H), 3.90 (s, 3H), 1.57 (br t, J 7.1 Hz, 3H), 1.31 (t, J 7.1 Hz, 3H);
13C NMR (125.8 MHz, CDCl3): d 163.56 (2 Â ), 159.00, 157.69, 157.68,
148.71, 148.64 (2 Â ), 148.27, 148.14, 147.57 (2 Â ), 147.48, 146.80, 146.72,
146.00, 145.76, 145.73, 145.47, 145.21, 144.86, 144.48, 144.34 (2 Â ), 144.13
(2 Â ), 143.92, 143.82, 143.63, 143.22, 143.01, 142.53, 142.42, 142.38, 141.82,
141.69, 141.52, 141.44, 140.78, 138.83, 130.07, 129.02, 128.21, 111.53, 71.03,
70.88, 66.07, 65.62, 63.30, 63.13, 56.28, 56.24, 50.81, 45.20, 14.27, 14.11; MS
7.36 (s, 2H), 4.41 (q, J 7.1 Hz, 4H), 4.04 (s, 6H), 1.37 (t, J 7.1 Hz, 6H);
13C NMR (125.8 MHz, CDCl3): d 163.21, 154.30, 154.07, 151.68, 148.48,
147.90, 147.81, 147.23, 146.93, 146.85, 146.56, 146.51, 146.33, 145.18, 145.17,
144.80, 144.76, 144.56, 144.45, 143.89, 143.80, 143.55, 143.16, 142.90, 142.84,
142.58, 142.46, 141.62, 141.02, 140.27, 139.05, 137.66, 106.55, 77.88, 71.68,
70.30, 63.11, 56.50, 50.81, 14.14; MS (FAB): m/z (%): 1014 ([M ], 57), 720
(C60 , 100).
(Æ)-Diethyl
63,64-bis[(acetoxy)methyl]-1,2-(but[2]eno)-33,50-meth-
ano[60]fullerene-61,61-dicarboxylate ((Æ)-5): To a solution of 15 (420 mg,
0.46 mmol) and diethyl 2-bromomalonate (0.11 mL, 0.69 mmol) in PhMe
(350 mL), DBU (0.13 mL, 0.92 mmol) was added and the solution was
stirred for 2 h. Plug filtration (SiO2; CH2Cl2 ! CH2Cl2/MeOH 95:5) and
column chromatography (SiO2; CH2Cl2/MeOH 98:2) gave (Æ)-5 (35 mg,
7%) as the second fraction. Preparative HPLC yielded analytically pure
(Æ)-5 (eluent PhMe/AcOEt 49:1, injection volume 500 mL (c
2.1 mgmLÀ1), flow rate 8.0 mLminÀ1, retention time 17 min). Analytical
HPLC purity control (eluent CH2Cl2, flow rate 2.0 mLminÀ1, retention
time 7.9 min); m.p. >2508C; UV/Vis (CH2Cl2): lmax (e) 701 (sh, 290), 630
(sh, 650), 475 (3150), 244 nm (125000 molÀ1 dm3 cmÀ1); IR (KBr): nÄ 2977,
(FAB): m/z (%): 1043 ([M ], 65), 720 (C60 , 55).
Tetraethyl 1,2:41,58-bis(methano)[70]fullerene-71,71,72,72-tetracarboxy-
late (11), (Æ)-tetraethyl 1,2:56,57-bis(methano)[70]fullerene-71,71,72,72-
tetracarboxylate ((Æ)-12), and (Æ)-tetraethyl 1,2:67,68-bis(methano)[70]-
fullerene-71,71,72,72-tetracarboxylate ((Æ)-13): The bis-adduct mixture 11,
(Æ)-12, and (Æ)-13 was prepared according to the literature.[6b] After
isolation of the mono-adduct fraction from the crude reaction mixture by
column chromatography (SiO2; PhMe), the regioisomeric bis-adducts were
separated by column chromatography (SiO2-H; PhMe/hexane 8:2) to yield,
in the order of elution: 11 (11%), (Æ)-12 (47%), and (Æ)-13 (13%). The
purity of each fraction was checked by HPLC (SiO2, PhMe, flow rate
1.0 mLminÀ1).
2922, 1741, 1367, 1229, 1016, 522 cmÀ1
;
1H NMR (500 MHz, CDCl3): d
5.24 (br s, 2H), 5.15 (br s, 2H), 4.61 ± 4.57 (m, 2H), 4.45 ± 4.38 (m, 2H), 4.16
(d, J 14.2 Hz, 1H), 4.10 (d, J 14.2 Hz, 1H), 3.94 (d, J 13.9 Hz, 1H),
3.88 (d, J 13.9 Hz, 1H), 2.10 (s, 3H), 1.94 (s, 3H), 1.51 (t, J 7.1 Hz, 3H),
1.38 (t, J 7.1 Hz, 3H); 13C NMR (125.8 MHz, CDCl3): d 170.93, 170.79,
163.52, 163.47, 148.72, 148.30, 148.28, 148.15, 148.02, 147.59 (2 Â ), 147.56,
147.53 (2 Â ), 147.47, 147.39, 146.79, 146.74, 146.21, 146.05, 145.95, 145.77,
145.49, 145.20, 144.85, 144.47, 144.36, 144.34, 144.20 (2 Â ), 144.14, 144.11,
143.94, 143.81, 143.65, 143.25, 143.10, 143.05, 142.44, 142.00, 141.83, 141.70,
141.54, 141.49, 141.25, 140.76, 139.50, 138.78, 137.62, 136.38 (2 Â ), 71.10,
70.93, 65.76, 65.24, 63.33, 63.15, 62.38, 62.30, 50.90, 43.21, 42.05, 20.09, 20.72,
61,61-Bis(p-methoxyphenyl)-1,2-methano[60]fullerene (17): Compound 17
was synthesized by a slightly modified literature procedure.[30b] C60 (1.2 g,
1.58 mmol) was dissolved in PhMe (600 mL), then BuLi (1.75 mL 1.6m
solution in hexane, 2.8 mmol) was added. A solution of 4,4'-dimethoxy-
benzophenone N-tosylhydrazone in PhMe (100 mL) was added, and the
mixture was heated to reflux for 1 h. After cooling to 208C, plug filtration
(SiO2; PhMe) yielded the crude product which was further purified by
column chromatography (SiO2; PhMe/hexane 3:2 ! 2:1). The mono-
adduct fraction that contained a mixture of the 6,6-closed and 6,5-open
mono-adducts was dissolved in PhMe (200 mL) and heated to reflux for
10 h. Finally, the solution was evaporated to dryness, dissolved in CH2Cl2,
and re-precipitated with hexane to yield pure 17 (550 mg, 37%). Analytical
data are in agreement with the literature.[30b]
14.82, 14.11; MS (FAB): m/z (%): 1077 ([M ], 48), 720 (C60 , 97); C77H24O8
(1077.0): calcd: C 85.87, H 2.25; found: C 85.90, H 2.42.
(Æ)-Diethyl
63-methyl-1,2-(methaniminomethano)-33,50-methano[60]
solution of 16 (260 mg,
fullerene-61,61-dicarboxylate ((Æ)-6): To
a
0.33 mmol), diethyl malonate (0.06 mL, 0.4 mmol), and I2 (126 mg,
0.5 mmol) in PhMe/CH2Cl2 (250 mL/200 mL), DBU (0.15 mL, 1.0 mmol)
was slowly added. After 2 h, diethyl malonate (0.12 mL, 0.8 mmol), I2
(252 mg, 1.0 mmol), and DBU (0.3 mL, 2.0 mmol) were added again and
the solution was stirred for another 2 h. Plug filtration (SiO2; CH2Cl2 !
CH2Cl2/MeOH 9:1) and column chromatography (SiO2; CH2Cl2) provided
(Æ)-6 (40 mg, 13%). Preparative HPLC yielded analytically pure (Æ)-4
(eluent PhMe, injection volume 500 mL (c 1.9 mg mLÀ1), flow rate
8.0 mLmin, retention time 75 min). Analytical HPLC purity control
1,1'-(Ethane-1,2-diyl) 3,3'-diethyl bis(malonate): Ethane-1,2-diol (250 mg,
4.03 mmol), ethyl 3-chloro-3-oxopropanoate (1.8 g, 12.1 mmol), and C5H5N
(0.96 g, 12.1 mmol) were mixed in CH2Cl2/THF (60 mL/10 mL), and the
solution was stirred for 12 h at 208C. The mixture was washed with
saturated aqueous NH4Cl solution (2 Â ), dried (MgSO4), and evaporated
to dryness. Column chromatography (SiO2; CH2Cl2/AcOEt 3:1) yielded the
desired product (1.013 g, 87%) as a colorless oil. IR (film): nÄ 2985, 1754,
1733, 1446, 1410, 1328, 1271, 1189, 1151, 1035, 979, 867, 841, 787, 681 cmÀ1
;
1H NMR (200 MHz, CDCl3): d 4.31 (s, 4H), 4.14 (q, J 7.5 Hz, 4H), 3.34
(eluent PhMe/AcOEt 9:1, flow rate 1.0 mLminÀ1
, retention time
(s, 4H), 1.22 (t, J 7.5 Hz, 6H); 13C NMR (50 MHz, CDCl3): d 165.90,
4.7 min); m.p. >2508C; UV/Vis (CH2Cl2): lmax (e) 700 (sh, 290), 620 (sh,
700), 473 (2500), 247 nm (105000 molÀ1 dm3 cmÀ1); IR (KBr): nÄ 2968,
2922, 2773, 1743, 1229, 526 cmÀ1; 1H NMR (500 MHz, CDCl3): d 4.62-4.58
(m, 2H), 4.42 (dq, J 7.1 Hz, 1.5 Hz, 2H), 4.41 (d, J 9.2 Hz, 1H), 4.35 (d,
J 9.2 Hz, 1H), 4.23 (d, J 9.3 Hz, 1H), 4.17 (d, J 9.3 Hz, 1H), 2.94 (s,
3H), 1.51 (t, J 7.1 Hz, 3H), 1.38 (t, J 7.1 Hz, 3H); 13C NMR (125.8 MHz,
CDCl3): d 163.53 (2 Â ), 156.87, 155.82, 155.63, 148.44, 148.09, 148.06,
148.01, 147.98, 147.88, 147.48, 147.46, 147.40 (2 Â ), 147.30, 147.19, 146.47,
146.31, 146.29, 146.15, 146.03, 145.88, 145.46, 145.29, 145.14, 144.99, 144.64,
144.55, 144.39, 144.28, 144.20, 144.16, 144.15, 143.91, 143.82, 143.71, 143.37
(2 Â ), 143.16, 143.10, 143.06, 143.02, 142.50, 142.00, 141.77, 141.69, 141.48,
141.46, 140.80, 139.90, 139.73, 139.47, 139.06, 138.80, 137.91, 136.75, 135.94,
71.10, 70.59, 70.15, 69.46, 63.31, 63.15, 56.57, 51.04, 41.61, 14.27, 14.12; MS
165.77, 62.28, 61.11, 40.82, 13.55; MS (EI): m/z (%): 291 [MH ]; C12H18O8
(290.3): calcd: C 49.65, H 6.25; found: C 49.42, H 6.03.
(Æ)-endo,endo-61,62-(Ethane-1,2-diyl) 61,62-diethyl 1,2:16,17-bis(meth-
ano)[60]fullerene-61,61,62,62-tetracarboxylate ((Æ)-21): To a solution of
C60 (300 mg, 0.416 mmol), 1,1'-(ethane-1,2-diyl) 3,3'-diethyl bis(malonate)
(145 mg, 0.5 mmol), and I2 (264 mg, 1.04 mmol) in PhMe (600 mL), DBU
(0.4 mL, 2.5 mmol) was slowly added under N2 at 208C and the mixture was
stirred for 12 h. Plug filtration (SiO2; CH2Cl2) and column chromatography
(SiO2; CH2Cl2) yielded (Æ)-21 (60 mg, 16%) as red-brown solid. M.p.
>2508C; UV/Vis (CH2Cl2): lmax (e) 699 (260), 634 (sh, 480), 459 (2140),
314 (34700), 253 nm (99300 molÀ1 dm3 cmÀ1); IR (film): nÄ 2967, 1745,
1439, 1362, 1230, 1097, 1050, 751, 525 cmÀ1 1H NMR (200 MHz, CDCl3):
;
(FAB): m/z (%): 936 ([M ], 35), 720 (C60 , 50).
d 5.27 (br d, J 11.2 Hz, 2H), 4.52 (q, J 7.1 Hz, 4H), 4.26 (br d, J
11.2 Hz, 2H), 1.47 (t, J 7.1 Hz, 6H); 13C NMR (125.8 MHz, CDCl3): d
163.91, 163.24, 146.71, 146.58, 145.58, 145.56, 145.55, 145.50, 145.43, 145.13,
144.96, 144.90, 144.56, 144.41, 144.14, 143.91, 143.65, 143.36, 142.49, 142.46,
142.45, 141.96, 141.07, 141.06, 140.87, 140.83, 140.55, 135.31, 128.75, 71.80,
(Æ)-Diethyl 64,65-dimethoxy-1,2-methano-33,50-(methano[1,2]benzeno
methano)[60]fullerene-69,69-dicarboxylate ((Æ)-8): To a solution of 1
(470 mg, 0.54 mmol) in PhMe (300 mL), 1,2-bis(bromomethyl)-4,5-dimeth-
oxybenzene (230 mg, 0.71 mmol) and Bu4NI (580 mg, 1.57 mmol) were
added and the mixture was heated to reflux for 16 h. After cooling to 208C,
the mixture was washed with water (3 Â ) and the organic phase dried
(MgSO4). Column chromatography (SiO2; PhMe/CH2Cl2 2:1) afforded five
fractions of which the second contained (Æ)-8 (12 mg, 2%). Preparative
HPLC yielded analytically pure (Æ)-8 (eluent PhMe, injection volume
500 mL (c 2.0 mg mLÀ1), flow rate 8.0 mLminÀ1, retention time 37 min).
68.56, 63.93, 63.57, 49.80, 14.22; (FAB): m/z (%): 1006 ([M ], 75), 720 (C60
,
100).
Electrochemistry: Fullerene mono- and bis-adducts (2 ± 3 mg) and sup-
porting electrolyte Bu4NPF6 (0.6 g) were added into a home-built two-
compartment electrolysis cell (for full description, see ref. [31]). The cell
was degassed and pumped to 10À6 mm Hg. The solvent, CH2Cl2 (14 mL),
which had also been degassed and pumped to the same pressure, was then
vapor-transferred into the cell, directly from P2O5. Prior to CPE, cyclic
Analytical HPLC purity control (eluent PhMe, flow rate 2.0 mLminÀ1
,
retention time 9.8 min); m.p. >2508C; UV/Vis (CH2Cl2): lmax (e) 700 (sh,
2190
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2000
0947-6539/00/0612-2190 $ 17.50+.50/0
Chem. Eur. J. 2000, 6, No. 12